Company

Zuellig Pharma Acquires Licensed Pharmaceutical Entity and Facility in Hangzhou, China – Strategic Move Strengthens Clinical Trial Sourcing Capabilities
Zuellig Pharma

Zuellig Pharma Acquires Licensed Pharmaceutical Entity and Facility in Hangzhou, China – Strategic Move Strengthens Clinical Trial Sourcing Capabilities

Zuellig Pharma, a leading healthcare services company in Asia, announced the strategic acquisition of a pharmaceutical entity and its facility in Hangzhou, China, holding a Drug Distribution License (DDL) —…

Alfasigma Reclaims Sulodexide Rights in China – Business Transfer to Add €25 Million in Annual Revenue and Drive 30 % Expansion of Alfasigma China

Alfasigma Reclaims Sulodexide Rights in China – Business Transfer to Add €25 Million in Annual Revenue and Drive 30 % Expansion of Alfasigma China

Bayer Q3 2026 Sales Reach €10.053 Billion as Pharmaceuticals Division Hits Growth Turning Point – Nubeqa and Kerendia Lead the Rebound

Bayer Q3 2026 Sales Reach €10.053 Billion as Pharmaceuticals Division Hits Growth Turning Point – Nubeqa and Kerendia Lead the Rebound

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
CF PharmTechClinical trial approval / initiation

CF PharmTech’s Inhaled siRNA Therapy ICF004 Receives NMPA Clinical Approval for Interstitial Lung Disease

HKG: 9996Peijia Medical

Peijia Medical Secures Exclusive China Distribution Rights for B. Braun’s SeQuent Please CIS Intracranial Drug-Coated Balloon

Basecare MedicalHKG: 2170

Basecare Medical Secures NMPA Category III Approval for Gems Oocyte Retrieval Solution in China’s IVF Market

BiosimilarsBoan Biotechnology

Shandong Boan Submits Dual Denosumab Biosimilar BLAs to FDA for Osteoporosis and Oncology Indications

Show More